May 27, 2026 08:30AM
Dec 17, 2025 02:21PM
May 28, 2025 08:30AM
May 29, 2024 08:30AM
Dec 7, 2023 09:22AM
Dec 7, 2023 04:29AM
Oct 5, 2023 08:30AM Vistagen to Present at Jefferies Inaugural Biotech CNS/Neuro Summit
Oct 2, 2023 07:31AM
Oct 2, 2023 07:30AM
Aug 10, 2023 04:22PM
Aug 10, 2023 04:21PM
Jun 6, 2023 04:30PM
May 27, 2022 08:30AM
Nov 16, 2021 08:30AM VistaGen Therapeutics to Present at the Jefferies London Healthcare Conference
Nov 16, 2021 08:30AM
Jun 29, 2021 04:15PM
Jun 29, 2021 04:15PM
May 20, 2021 08:00AM
Feb 18, 2021 09:23AM
Feb 18, 2021 05:38AM
Feb 11, 2021 04:30PM VistaGen Therapeutics Reports Fiscal 2021 Third Quarter Financial Results and Provides Update on Expected Clinical Studies in Calendar 2021
Feb 11, 2021 04:30PM
Dec 22, 2020 04:01PM
Dec 22, 2020 04:01PM
Dec 18, 2020 06:27AM
Dec 18, 2020 06:25AM
Dec 17, 2020 04:01PM
Dec 17, 2020 04:01PM VistaGen Therapeutics Announces Proposed Underwritten Public Offering

72,076 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All